Prognostic Role of HER2 Status and Adjuvant Trastuzumab Treatment in Lymph Node-Negative Breast Cancer Patients - a Retrospective Single Center Analysis

BACKGROUND: The natural course of traditionally prognostically unfavorable human epidermal growth factor receptor 2 (HER2)-positive breast cancer has been changed by anti-HER2 therapy. It is not clear whether the prognosis for HER2-positive patients treated with adjuvant trastuzumab differs from tha...

Full description

Saved in:
Bibliographic Details
Published in:Breast Care (Basel)
Main Authors: Fokter Dovnik, Nina, Dovnik, Andraž, Čas Sikošek, Nina, Ravnik, Maja, Arko, Darja, Takač, Iztok
Format: Artigo
Language:Inglês
Published: S. Karger GmbH 2016
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290447/
https://ncbi.nlm.nih.gov/pubmed/28228707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000454690
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items